The syntheses of novel bulky N-substituted 1,3-benzazaphospholes are presented, together with their reactions with tert-butyllithium and coupling with tBu 2PCl to novel P, P'-hybrid ligands that combine the highly basic and bulky di- tert-butylphosphanyl group with pi-acidic low-coordinated phosphorus. The syntheses start with the preparation of new N-secondary 2-bromoanilines 1 by reduction of N-acyl 2-bromoanilides or more generally by Pd-catalyzed selective monoamination of o-dibromobenzene, followed by Pd-catalyzed C-P coupling with P(OEt) 3 to the respective 2-anilino-phosphonates 2. The next steps are reduction to 2-phosphanylanilines 3 and condensation with Me 2NCH(OMe) 2, which leads via phosphaalkenes 4 to the corresponding N-substituted benzazaphospholes 5. The reaction with tBuLi depends on the steric demand of the N substituent. Methyl, neopentyl-, and mesityl-derivatives were converted to P=C Li species 6 and coupled with tBu 2PCl to novel P=C-P tBu 2 ligands 7, whereas N-adamantyl and N-2,6-diisopropylphenyl-derivatives prefer addition of tBuLi at the PC bond to form dihydroderivatives. The chemical shifts of the low-coordinated phosphorus of 5 and 7 were found to reflect electronic and steric effects of the N substituents. The comparison of the crystal structures of N-neopentyl-1,3-benzazaphospholes 5 and 7 gives evidence of steric repulsion between the adjacent di- tert-butyl and neopentyl groups by the preferred anti orientation of the P- tert-butyl groups and moderate deviations of C2 and P3 of 7b from the ring plane.
No takes yet. Share an insight, caveat, or question.
Aluri et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: